4th Quarter - Report

BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 15, 2014 $400,000 Replaced
4th Quarter - Amendment Jan 15, 2014 $400,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S.232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devicesH.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corportae tax rate, research credit transition and base erosion

LobbyistCovered position, as disclosed
BRENDA BECKER —
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1295 (113th), H.R. 523 (113th), H.R. 905 (113th), S. 232 (113th)

Copyright/Patent/Trademark CPT

H.R. 2024 - End Annonymous Patents Act -- A bill to end frivolous Patent lawsuits H.R. 845 - Saving High-Tech Innocations from Egregious Legal Disputes Act of 2013 - A bill to end frivolous Patent lawsuits S. 1013 - Patent Abuse Reduction Act of 2013 - (Cornyn) A bill to end frivolous Patent lawsuitsS. 866 - Patent Quality Improvement Act of 2013 - A bill to make improvements to the transitional program covered business method patents H.R. 3309 - (Goodlatte) "Innovation Act" - A bill to end frivolous Patent lawsuits H.R. 3349 - (Conyers ) "Innovation Protection Act" - A bill to end frivolous Patent lawsuits H.R. 2766 - (Issa, Chu) "STOP Act" - To make improvements to the transitional program for covered business method patents S. 1720 - (Leahy-Lee) - "America Invents Act" - A bill to promote transparency in patent ownership and make other improvements to the patent system.

LobbyistCovered position, as disclosed
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 3309 (113th), H.R. 2766 (113th), H.R. 3349 (113th), H.R. 2024 (113th), S. 1720 (113th), H.R. 845 (113th), S. 1013 (113th)

Health Issues HCR

Public Law 112-144 - Implementation Food and Drug Administration Safety and Innovation Act FDASIA H.R. 1919 - Safeguarding Pharmaceuticals Act of 2013 - Track and Trace Pedigree Program S. 957 - Drug Supply Chain Security Act - Track and Trace Pedigree Program H.R. 3204 - Drug Quality & Security Act - Became Public Law 113-54 - Track and Trace Pedigree Program

LobbyistCovered position, as disclosed
BRENDA BECKER —
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1919 (113th), H.R. 3204 (113th), S. 957 (113th)

Budget/Appropriations BUD

H.R. 933 - Consolidfated and Further Continuing Appropriations Act, 2013 -- Specificaly provisions providing appropriations for the FDA's Center for Device and Radiological Health (CDRH) evaluation of medical technology -- In particular have been working on relief of 5% sequestration of user fees H.J. Res 59 - Continuing Appropriations Resolution - Specificaly provisions providing appropriations for the FDA's Center for Device and Radiological Health (CDRH) evaluation of medical technology

LobbyistCovered position, as disclosed
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.J.Res. 59 (113th), H.R. 933 (113th)

Computer Industry CPI

H.R. 624 - CyberIntelligence Sharing & Protection Act (CISPA) of 2013 - A bill to promote Industry and Government sharing of cyber intelligence S. 1788 - Digital Trade Act of 2013 - A bill to promote internet enabled commerce and digital trade. H.R. 3696 - National Cyber Security & Critical Infrastructure Protection Act 2013 - A bill to make improvements regarding cyber security and critical infrastructure protection.

LobbyistCovered position, as disclosed
BRENDA BECKER —
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 624 (113th), S. 1788 (113th), H.R. 3696 (113th)

Education EDU

S. 358 - STEM Master Teach Corps Act of 2013 - to promote STEM education H.R. 1243 - Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 1089 - Stepping up to STEM Act of 2013 - to promote STEM education

LobbyistCovered position, as disclosed
KRISTEN HEDSTROM —
STEVEN NEIL LAPIERRE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 358 (113th), H.R. 1089 (113th), H.R. 1243 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.